Breaking News Instant updates and real-time market news.

2020-06-08 16:08:23 EYE National Vision $31.61 / -0.18 (-0.57%) 16:08 06/08/20 06/08 16:08 06/08/20 16:08	National Vision estimates one-month April SSS down 83.9%, May down 56.6% The company states that it "continues to expect second quarter results to be materially impacted by the store closures during the month of April, deleveraging of optometrist costs and associate payroll expense, shifts in product mix with reduced margin implications, the timing of unearned revenue, and incremental COVID-related costs. As part of the store re-openings, the company has brought back most of its furloughed associates and has begun the return to previous levels of compensation and work hours across the organization, including with respect to executive officers other than the CEO. In addition, the company restarted unit growth in May by opening three new America's Best Contacts & Eyeglasses stores. Management now expects to open as many as 25 to 30 additional stores between now and the end of 2020, for a total of between 50 and 55 new store openings for the full year, below the withdrawn 2020 outlook of approximately 75 new stores."	10 Jun
EYE National Vision $31.61 / -0.18 (-0.57%) 05/08/20 Guggenheim National Vision price target lowered to $35 from $45 at Guggenheim 04/17/20 Barclays National Vision price target lowered to $28 from $44 at Barclays 03/24/20 Citi National Vision price target lowered to $34 from $44 at Citi 03/23/20 Wells Fargo National Vision price target lowered to $22 from $42 at Wells Fargo

2020-06-08 16:08:23

EYE

National Vision

$31.61 / -0.18 (-0.57%)

16:08

06/08/20

06/08

16:08

06/08/20

16:08

National Vision estimates one-month April SSS down 83.9%, May down 56.6%

The company states that it "continues to expect second quarter results to be materially impacted by the store closures during the month of April, deleveraging of optometrist costs and associate payroll expense, shifts in product mix with reduced margin implications, the timing of unearned revenue, and incremental COVID-related costs. As part of the store re-openings, the company has brought back most of its furloughed associates and has begun the return to previous levels of compensation and work hours across the organization, including with respect to executive officers other than the CEO. In addition, the company restarted unit growth in May by opening three new America's Best Contacts & Eyeglasses stores. Management now expects to open as many as 25 to 30 additional stores between now and the end of 2020, for a total of between 50 and 55 new store openings for the full year, below the withdrawn 2020 outlook of approximately 75 new stores."

10
Jun

EYE National Vision

$31.61 / -0.18 (-0.57%)

05/08/20 Guggenheim: National Vision price target lowered to $35 from $45 at Guggenheim

04/17/20 Barclays: National Vision price target lowered to $28 from $44 at Barclays

03/24/20 Citi: National Vision price target lowered to $34 from $44 at Citi

03/23/20 Wells Fargo: National Vision price target lowered to $22 from $42 at Wells Fargo

TODAY'S FREE FLY STORIES

Initiation	Exact Sciences initiated with a Buy at Truist » 16:18 01/27/21 01/27 16:18 01/27/21 16:18 EXAS Exact Sciences $136.58 / -4.39 (-3.11%) Truist analyst Sandy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options EXAS Exact Sciences $136.58 / -4.39 (-3.11%) 01/13/21 Exact Sciences reports worldwide exclusive license for TARDIS technology 01/12/21 Exact Sciences announces new data on Cologuard published in cancer journal 12/09/20 House passes Removing Barriers to Colorectal Cancer Screening Act 12/09/20 Exact Sciences-Oncotype test used to determine benefit of chemotherapy EXAS Exact Sciences $136.58 / -4.39 (-3.11%) 01/12/21 Stifel Renalytix AI, Exact Sciences may benefit from final MCIT rule, says Stifel 01/12/21 Canaccord Exact Sciences price target raised to $165 from $160 at Canaccord 01/12/21 Oppenheimer Exact Sciences price target raised to $161 from $153 at Oppenheimer 12/17/20 BTIG BTIG positive on select healthcare diagnostic/tools names as '2021 Top Picks' EXAS Exact Sciences $136.58 / -4.39 (-3.11%) 01/10/21 Exact Sciences reports preliminary Q4 revenue $464.5M-$467.5M, consensus $431.2M 10/27/20 Exact Sciences reports Q3 EPS ($1.46), consensus (52c) 07/30/20 Exact Sciences reports Q2 EPS (58c), consensus (63c) 07/30/20 Notable companies reporting after market close EXAS Exact Sciences $136.58 / -4.39 (-3.11%) 10/28/20 AMD, Lululemon upgrades among today's top calls on Wall Street 10/27/20 Fly Intel: Wall Street's top stories for Tuesday 10/27/20 Fly Intel: Wall Street's top stories at midday EXAS Exact Sciences $136.58 / -4.39 (-3.11%) 10/23/20 EXACT Sciences call volume above normal and directionally bullish
Hot Stocks	Mid-Southern Bancorp increases quarterly cash dividend 50% to 3c per share » 16:18 01/27/21 01/27 16:18 01/27/21 16:18 MSVB Mid-Southern Bancorp $15.48 / + (+0.00%) Mid-Southern Bancorp… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News MSVB Mid-Southern Bancorp $15.48 / + (+0.00%) 08/31/20 Mid-Southern Bancorp announces adoption of additional stock repurchase program
Earnings	CACI sees FY21 EPS $14.47-$15.25, consensus $15.01 » 16:17 01/27/21 01/27 16:17 01/27/21 16:17 CACI CACI $259.76 / +6.38 (+2.52%) Sees FY21 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CACI CACI $259.76 / +6.38 (+2.52%) 01/26/21 CACI awarded $96M task order by U.S. Army 12/10/20 Air Force awards CACI $160M task order to provide information technology support 10/22/20 CACI awarded up to $86.5M, five-year DHS contract 09/29/20 CACI awarded up to $59M task order by OUSD for operational support CACI CACI $259.76 / +6.38 (+2.52%) 09:59 Today Stifel CACI 'very likely' to bid on Perspecta as well, says Stifel 09/22/20 JPMorgan JPMorgan upgrades 'relatively resilient' CACI to Overweight 09/22/20 JPMorgan CACI upgraded to Overweight from Neutral at JPMorgan 08/14/20 Stifel CACI price target raised to $300 from $295 at Stifel CACI CACI $259.76 / +6.38 (+2.52%) 16:17 Today CACI reports Q2 EPS $4.18, consensus $3.60 10/28/20 CACI raises FY21 EPS view to $14.47-$15.25 from $13.50-$14.28 10/28/20 CACI reports Q1 EPS $3.67, consensus $3.11 08/12/20 CACI reports Q4 EPS $3.68, consensus $3.44 02/09/21 42nd Annual Aerospace/Defense & Industrials Virtual Conference 01/28/21 CACI - CACI
Earnings	NextGen Healthcare backs FY21 adjusted EPS view 92c-98c, consensus 96c » 16:17 01/27/21 01/27 16:17 01/27/21 16:17 NXGN NextGen Healthcare $21.82 / -1.535 (-6.57%) Backs FY21 revenue view… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Events NXGN NextGen Healthcare $21.82 / -1.535 (-6.57%) 01/14/21 RBC Capital NextGen Healthcare price target raised to $21 from $14 at RBC Capital 10/23/20 SVB Leerink NextGen Healthcare price target raised to $14 from $12 at SVB Leerink 10/23/20 Piper Sandler NextGen Healthcare price target lowered to $21 from $23 at Piper Sandler 07/31/20 Piper Sandler NextGen Healthcare price target raised to $23 from $17 at Piper Sandler NXGN NextGen Healthcare $21.82 / -1.535 (-6.57%) 16:17 Today NextGen Healthcare reports Q3 adjusted EPS 26c, consensus 25c 01/13/21 NextGen Healthcare sees FY21 EPS 92c-98c, consensus 89c 01/13/21 NextGen Healthcare sees Q3 EPS 24c-26c, consensus 19c 10/22/20 NextGen Healthcare reinstates FY21 EPS outlook 83c-93c, consensus 83c 17:00 Today NextGen Healthcare - NXGN
Hot Stocks	ServiceNow reports Q4 subscription billings $1.83B, up 41% from last year 16:17 01/27/21 01/27 16:17 01/27/21 16:17 NOW ServiceNow $518.15 / -14.66 (-2.75%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NOW ServiceNow $518.15 / -14.66 (-2.75%) 05:27 Today NHS Scotland selects ServiceNow to aid 5.5M citizen vaccinations 01/13/21 SurveyMonkey announces integration with ServiceNow 12/17/20 Exfo joins ServiceNow Partner Program 11/30/20 ServiceNow says 2020 margin profile 'not sustainable' NOW ServiceNow $518.15 / -14.66 (-2.75%) 01/22/21 OTR Global ServiceNow upgraded to Positive from Mixed at OTR Global 01/22/21 Cowen ServiceNow price target raised to $600 from $575 at Cowen 01/21/21 Goldman Sachs ServiceNow assumed with a Buy at Goldman Sachs 01/14/21 Oppenheimer ServiceNow upgraded to Outperform at Oppenheimer on glide path to $10B in sales NOW ServiceNow $518.15 / -14.66 (-2.75%) 16:17 Today ServiceNow reports Q4 subscription billings $1.83B, up 41% from last year 16:12 Today ServiceNow reports Q4 adjusted EPS $1.17, consensus $1.05 14:30 Today Notable companies reporting after market close 10/28/20 ServiceNow raises 2020 subscription revenue outlook to $4.25B-$4.26B NOW ServiceNow $518.15 / -14.66 (-2.75%) 01/14/21 Shopify, Intel upgrades among today's top calls on Wall Street 12/16/20 Microsoft reinstatement, Spotify downgrade among top calls on Wall Street 11/24/20 Target upgrade, Microsoft initiation among today's top calls on Wall Street 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street 17:00 Today ServiceNow - NOW

Earnings	NextGen Healthcare reports Q3 adjusted EPS 26c, consensus 25c » 16:17 01/27/21 01/27 16:17 01/27/21 16:17 NXGN NextGen Healthcare $21.82 / -1.535 (-6.57%) Reports Q3 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events NXGN NextGen Healthcare $21.82 / -1.535 (-6.57%) 01/14/21 RBC Capital NextGen Healthcare price target raised to $21 from $14 at RBC Capital 10/23/20 SVB Leerink NextGen Healthcare price target raised to $14 from $12 at SVB Leerink 10/23/20 Piper Sandler NextGen Healthcare price target lowered to $21 from $23 at Piper Sandler 07/31/20 Piper Sandler NextGen Healthcare price target raised to $23 from $17 at Piper Sandler NXGN NextGen Healthcare $21.82 / -1.535 (-6.57%) 01/13/21 NextGen Healthcare sees FY21 EPS 92c-98c, consensus 89c 01/13/21 NextGen Healthcare sees Q3 EPS 24c-26c, consensus 19c 10/22/20 NextGen Healthcare reinstates FY21 EPS outlook 83c-93c, consensus 83c 10/22/20 NextGen Healthcare reports Q2 EPS 30c, consensus 20c 17:00 Today NextGen Healthcare - NXGN
Earnings	Edwards Lifesciences sees Q1 adjusted EPS 43c-50c, consensus 50c » 16:17 01/27/21 01/27 16:17 01/27/21 16:17 EW Edwards Lifesciences $84.88 / -1.64 (-1.90%) Sees Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options EW Edwards Lifesciences $84.88 / -1.64 (-1.90%) 12/21/20 Edwards Lifesciences: First patient treated in RESTORE clinical trial 12/18/20 Edwards Lifesciences receives expanded approval for SAPIEN 3 TAVI in Canada 12/10/20 Edwards Lifesciences sees FY21 gross profit margin 76%-77% 12/10/20 Edwards Lifesciences sees FY21 CapEx ~$350M EW Edwards Lifesciences $84.88 / -1.64 (-1.90%) 01/13/21 Piper Sandler MCIT finalized rule 'important win' for medical technology, says Piper Sandler 12/16/20 Citi Edwards Lifesciences downgraded to Neutral from Buy at Citi 12/11/20 Canaccord Edwards Lifesciences price target raised to $94 from $89 at Canaccord 12/11/20 Piper Sandler Edwards Lifesciences price target raised to $98 from $93 at Piper Sandler EW Edwards Lifesciences $84.88 / -1.64 (-1.90%) 16:16 Today Edwards Lifesciences backs FY21 adjusted EPS view $2.00-$2.20, consensus $2.15 16:15 Today Edwards Lifesciences reports Q4 adjusted EPS 50c, consensus 53c 14:30 Today Notable companies reporting after market close 12/10/20 Edwards Lifesciences sees FY21 adjusted EPS $2.00-$2.20, consensus $2.22 EW Edwards Lifesciences $84.88 / -1.64 (-1.90%) 10/21/20 Fly Intel: After-Hours Movers 03/01/21 41st Annual Healthcare Virtual Conference 17:00 Today Edwards Lifesciences - EW EW Edwards Lifesciences $84.88 / -1.64 (-1.90%) 11/17/20 Early notable gainers among liquid option names on November 17th
Earnings	CACI reports Q2 EPS $4.18, consensus $3.60 » 16:17 01/27/21 01/27 16:17 01/27/21 16:17 CACI CACI $259.76 / +6.38 (+2.52%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CACI CACI $259.76 / +6.38 (+2.52%) 01/26/21 CACI awarded $96M task order by U.S. Army 12/10/20 Air Force awards CACI $160M task order to provide information technology support 10/22/20 CACI awarded up to $86.5M, five-year DHS contract 09/29/20 CACI awarded up to $59M task order by OUSD for operational support CACI CACI $259.76 / +6.38 (+2.52%) 09:59 Today Stifel CACI 'very likely' to bid on Perspecta as well, says Stifel 09/22/20 JPMorgan JPMorgan upgrades 'relatively resilient' CACI to Overweight 09/22/20 JPMorgan CACI upgraded to Overweight from Neutral at JPMorgan 08/14/20 Stifel CACI price target raised to $300 from $295 at Stifel CACI CACI $259.76 / +6.38 (+2.52%) 10/28/20 CACI raises FY21 EPS view to $14.47-$15.25 from $13.50-$14.28 10/28/20 CACI reports Q1 EPS $3.67, consensus $3.11 08/12/20 CACI reports Q4 EPS $3.68, consensus $3.44 02/09/21 42nd Annual Aerospace/Defense & Industrials Virtual Conference 01/28/21 CACI - CACI
Technical Analysis	NASDAQ market internals summary » 16:17 01/27/21 01/27 16:17 01/27/21 16:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume was above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 15:17 Today NASDAQ market internals summary 14:17 Today NASDAQ market internals summary 13:17 Today NASDAQ market internals summary 12:17 Today NASDAQ market internals summary
Earnings	TriState Capital reports Q4 EPS 37c, consensus 26c » 16:16 01/27/21 01/27 16:16 01/27/21 16:16 TSC TriState Capital $18.16 / -0.83 (-4.37%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events TSC TriState Capital $18.16 / -0.83 (-4.37%) 10/12/20 TriState Capital in pact for $105M in new capital to fund 'high-growth' TSC TriState Capital $18.16 / -0.83 (-4.37%) 01/07/21 B. Riley Securities TriState Capital price target raised to $19 from $18 at B. Riley Securities 01/04/21 Stephens Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens 12/04/20 B. Riley Securities TriState Capital price target raised to $18 from $15 at B. Riley Securities 10/13/20 Boenning & Scattergood TriState Capital resumed with a Neutral at Boenning & Scattergood TSC TriState Capital $18.16 / -0.83 (-4.37%) 10/21/20 TriState Capital reports Q3 EPS 26c, consensus 21c 06 Feb 01/28/21 TriState Capital - TSC

Earnings	Edwards Lifesciences backs FY21 adjusted EPS view $2.00-$2.20, consensus $2.15 » 16:16 01/27/21 01/27 16:16 01/27/21 16:16 EW Edwards Lifesciences $84.88 / -1.64 (-1.90%) Backs FY21 revenue view… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options EW Edwards Lifesciences $84.88 / -1.64 (-1.90%) 12/21/20 Edwards Lifesciences: First patient treated in RESTORE clinical trial 12/18/20 Edwards Lifesciences receives expanded approval for SAPIEN 3 TAVI in Canada 12/10/20 Edwards Lifesciences sees FY21 gross profit margin 76%-77% 12/10/20 Edwards Lifesciences sees FY21 CapEx ~$350M EW Edwards Lifesciences $84.88 / -1.64 (-1.90%) 01/13/21 Piper Sandler MCIT finalized rule 'important win' for medical technology, says Piper Sandler 12/16/20 Citi Edwards Lifesciences downgraded to Neutral from Buy at Citi 12/11/20 Canaccord Edwards Lifesciences price target raised to $94 from $89 at Canaccord 12/11/20 Piper Sandler Edwards Lifesciences price target raised to $98 from $93 at Piper Sandler EW Edwards Lifesciences $84.88 / -1.64 (-1.90%) 16:15 Today Edwards Lifesciences reports Q4 adjusted EPS 50c, consensus 53c 14:30 Today Notable companies reporting after market close 12/10/20 Edwards Lifesciences sees FY21 adjusted EPS $2.00-$2.20, consensus $2.22 10/21/20 Edwards Lifesciences sees Q4 underlying sales growth 'similar' to Q3 EW Edwards Lifesciences $84.88 / -1.64 (-1.90%) 10/21/20 Fly Intel: After-Hours Movers 03/01/21 41st Annual Healthcare Virtual Conference 17:00 Today Edwards Lifesciences - EW EW Edwards Lifesciences $84.88 / -1.64 (-1.90%) 11/17/20 Early notable gainers among liquid option names on November 17th
Technical Analysis	NYSE market internals summary » 16:16 01/27/21 01/27 16:16 01/27/21 16:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume was above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 15:16 Today NYSE market internals summary 14:16 Today NYSE market internals summary 13:16 Today NYSE market internals summary 12:16 Today NYSE market internals summary
Earnings	John B. Sanfilippo & Son reports Q2 EPS $1.72, one estimate $1.43 » 16:16 01/27/21 01/27 16:16 01/27/21 16:16 JBSS John B. Sanfilippo & Son $78.56 / -2.67 (-3.29%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events JBSS John B. Sanfilippo & Son $78.56 / -2.67 (-3.29%) 16:14 Today John B. Sanfilippo & Son declares special cash dividend of $2.50 per share 08/19/20 John B. Sanfilippo & Son CEO seeing 'significant improvement in food service' JBSS John B. Sanfilippo & Son $78.56 / -2.67 (-3.29%) 09/04/20 Sidoti John B. Sanfilippo & Son upgraded to Buy from Neutral at Sidoti 04/07/20 Sidoti John B. Sanfilippo & Son downgraded to Neutral from Buy at Sidoti 03/02/20 Sidoti Sidoti upgrades John B. Sanfilippo to Buy, sees little impact from coronavirus 03/02/20 Sidoti John B. Sanfilippo & Son upgraded to Buy from Neutral at Sidoti JBSS John B. Sanfilippo & Son $78.56 / -2.67 (-3.29%) 08/19/20 John B. Sanfilippo & Son reports Q2 EPS 89c, one estimate 91c 01/28/21 John B. Sanfilippo & Son - JBSS
Initiation	Academy Sports initiated with a Buy at Loop Capital » 16:15 01/27/21 01/27 16:15 01/27/21 16:15 ASO Academy Sports $22.02 / -2.22 (-9.16%) Loop Capital initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options ASO Academy Sports $22.02 / -2.22 (-9.16%) 12/10/20 Academy Sports CFO says 'inventory is now at an acceptable level' 12/10/20 Academy Sports reports Q3 gross margin 32.7% 12/10/20 Academy Sports reports Q3 SSS up 16.5% ASO Academy Sports $22.02 / -2.22 (-9.16%) 10/27/20 Fly Intel: Top five analyst initiations 10/27/20 UBS Academy Sports initiated with a Buy at UBS 10/27/20 Credit Suisse Academy Sports initiated with an Outperform at Credit Suisse 10/27/20 JPMorgan Academy Sports initiated with an Overweight at JPMorgan ASO Academy Sports $22.02 / -2.22 (-9.16%) 12/10/20 Academy Sports reports Q3 adjusted EPS 91c, consensus 36c 28 Jan 02 Oct ASO Academy Sports $22.02 / -2.22 (-9.16%) 01/25/21 Fly Intel: After-Hours Movers 10/04/20 Opening Day: Palantir, Asana go public via direct listings ASO Academy Sports $22.02 / -2.22 (-9.16%) 12/07/20 Four new option listings and one option delisting on December 7th
Hot Stocks	Tesla down $50.26, or 6%, to $813.90 after Q4 report 16:15 01/27/21 01/27 16:15 01/27/21 16:15 TSLA Tesla $864.66 / -18.83 (-2.13%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TSLA Tesla $864.66 / -18.83 (-2.13%) 16:14 Today Tesla sees 2021 as 'even more important' than 2020 01/26/21 Elon Musk says Tesla 'has better AI hardware and software than Waymo' 01/21/21 Greenlight discloses new positions in Resideo and NCR, discusses FuboTV stake 01/20/21 Chanos says short Tesla stock position transferred into put position TSLA Tesla $864.66 / -18.83 (-2.13%) 08:58 Today Roth Capital Positive results 'clearly' priced into Tesla stock, says Roth Capital 08:42 Today Credit Suisse Positive deliveries guide could be catalyst for Tesla stock, says Credit Suisse 01/26/21 Credit Suisse Credit Suisse could see software, battery as key underpinnings of Apple car 01/25/21 Morgan Stanley Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value TSLA Tesla $864.66 / -18.83 (-2.13%) 16:11 Today Tesla reports Q4 non-GAAP EPS 80c, consensus $1.01 14:30 Today Notable companies reporting after market close 10/21/20 Tesla reports Q3 non-GAAP EPS 76c, consensus 56c 10/21/20 Notable companies reporting after market close 14 Feb TSLA Tesla $864.66 / -18.83 (-2.13%) 01/25/21 Tesla accuses engineer of stealing trade secrets, Business Insider reports 01/22/21 Waymo CEO: Tesla Autopilot will fall short of full autonomy, Bloomberg reports 01/21/21 Tesla's Q4 California registrations inccrease 63%, Reuters reports 01/20/21 Tesla lowers Model 3 prices in Europe, Electrek reports TSLA Tesla $864.66 / -18.83 (-2.13%) 15:10 Today Nokia soars but company 'not aware' of apparent reason for trading activity 12:13 Today Fly Intel: What to watch in Tesla earnings report 01/25/21 Walmart downgrade, Alibaba initiation among today's top calls on Wall Street 01/23/21 Charged: Oppenheimer ups Tesla target to Street-high $1,036 18:30 Today Tesla - TSLA TSLA Tesla $864.66 / -18.83 (-2.13%) 15:04 Today Tesla options imply 13.3% move in share price post-earnings 01/20/21 Notable open interest changes for January 20th 01/13/21 Notable open interest changes for January 13th 01/12/21 Notable open interest changes for January 12th

Earnings	Edwards Lifesciences reports Q4 adjusted EPS 50c, consensus 53c » 16:15 01/27/21 01/27 16:15 01/27/21 16:15 EW Edwards Lifesciences $84.87 / -1.65 (-1.91%) Reports Q4 revenue $1.2B,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options EW Edwards Lifesciences $84.87 / -1.65 (-1.91%) 12/21/20 Edwards Lifesciences: First patient treated in RESTORE clinical trial 12/18/20 Edwards Lifesciences receives expanded approval for SAPIEN 3 TAVI in Canada 12/10/20 Edwards Lifesciences sees FY21 gross profit margin 76%-77% 12/10/20 Edwards Lifesciences sees FY21 CapEx ~$350M EW Edwards Lifesciences $84.87 / -1.65 (-1.91%) 01/13/21 Piper Sandler MCIT finalized rule 'important win' for medical technology, says Piper Sandler 12/16/20 Citi Edwards Lifesciences downgraded to Neutral from Buy at Citi 12/11/20 Canaccord Edwards Lifesciences price target raised to $94 from $89 at Canaccord 12/11/20 Piper Sandler Edwards Lifesciences price target raised to $98 from $93 at Piper Sandler EW Edwards Lifesciences $84.87 / -1.65 (-1.91%) 14:30 Today Notable companies reporting after market close 12/10/20 Edwards Lifesciences sees FY21 adjusted EPS $2.00-$2.20, consensus $2.22 10/21/20 Edwards Lifesciences sees Q4 underlying sales growth 'similar' to Q3 10/21/20 Edwards Lifesciences raises FY20 adj. EPS view to $1.85-$1.95 from $1.75-$1.95 EW Edwards Lifesciences $84.87 / -1.65 (-1.91%) 10/21/20 Fly Intel: After-Hours Movers 03/01/21 41st Annual Healthcare Virtual Conference 17:00 Today Edwards Lifesciences - EW EW Edwards Lifesciences $84.87 / -1.65 (-1.91%) 11/17/20 Early notable gainers among liquid option names on November 17th
Hot Stocks	Bonanza Creek sees Q4 sales volumes 25 MBoe/d » 16:15 01/27/21 01/27 16:15 01/27/21 16:15 BCEI Bonanza Creek $20.07 / -0.175 (-0.86%) Bonanza Creek Energy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings BCEI Bonanza Creek $20.07 / -0.175 (-0.86%) 12/22/20 Bonanza Creek announces results of borrowing base redetermination 11/09/20 Bonanza Creek and HighPoint Resources enter into definitive merger agreement 11/09/20 Bonanza Creek to acquire HighPoint Resources in $376M deal 11/09/20 Bonanza Creek to acquire HighPoint Resources in $376M deal BCEI Bonanza Creek $20.07 / -0.175 (-0.86%) 11/23/20 Stifel HighPoint Resources downgraded to Sell from Buy at Stifel 11/12/20 Truist Bonanza Creek price target raised to $25 from $21 at Truist 09/25/20 Wells Fargo Bonanza Creek initiated with an Overweight at Wells Fargo 07/27/20 Seaport Global Bonanza Creek initiated with a Buy at Seaport Global BCEI Bonanza Creek $20.07 / -0.175 (-0.86%) 11/05/20 Bonanza Creek reports Q3 adj. EPS 50c, consensus 77c 08/06/20 Bonanza Creek reports Q2 EPS 61c, consensus 61c
Earnings	Accuray reports Q2 EPS 5c, consensus (2c) » 16:14 01/27/21 01/27 16:14 01/27/21 16:14 ARAY Accuray $5.21 / +0.05 (+0.97%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ARAY Accuray $5.21 / +0.05 (+0.97%) 01/19/21 Accuray reports data from phase II trial using TomoTherapy System 01/05/21 Accuray receives FDA clearance for its Helical kVCT Imaging 11/18/20 Accuray, DHL Supply Chain enter logistics partnership 11/12/20 Accuray director Whitters buys 50,000 shares ARAY Accuray $5.21 / +0.05 (+0.97%) 01/07/21 Fly Intel: Top five analyst initiations 01/07/21 Northland Accuray initiated with an Outperform at Northland 09/28/20 Lake Street CMS 'pouring fuel on the fire' for Accuray with APM rule, says Lake Street 09/18/20 Cowen New CMS model should provide tailwind for Accuray, says Cowen ARAY Accuray $5.21 / +0.05 (+0.97%) 10/29/20 Accuray reports Q1 EPS 0c, consensus (7c) 08/13/20 Accuray not providing FY21 guidance 08/13/20 Accuray reports Q4 EPS (1c), consensus (2c) ARAY Accuray $5.21 / +0.05 (+0.97%) 10/29/20 Fly Intel: After-Hours Movers 08/13/20 Fly Intel: After-Hours Movers 03/01/21 41st Annual Healthcare Virtual Conference 16:30 Today Accuray - ARAY
Earnings	Stryker sees FY21 adjusted EPS $8.80-$9.20, consensus $9.13 » 16:14 01/27/21 01/27 16:14 01/27/21 16:14 SYK Stryker $230.62 / -7.38 (-3.10%) The company said,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SYK Stryker $230.62 / -7.38 (-3.10%) 01/05/21 Stryker acquires OrthoSensor, terms not disclosed 12/17/20 FTC approves final conditions on Stryker acquisition of Wright Medical 11/11/20 Stryker completes acquisition of Wright Medical 11/11/20 Stryker announces intention to complete Wright Medical acquisition SYK Stryker $230.62 / -7.38 (-3.10%) 01/06/21 Truist Stryker price target raised to $245 from $210 at Truist 01/06/21 Credit Suisse Stryker price target raised to $278 from $253 at Credit Suisse 01/04/21 Guggenheim Stryker resumed with a Neutral at Guggenheim 12/31/20 BTIG Stryker price target raised to $252 from $234 at BTIG SYK Stryker $230.62 / -7.38 (-3.10%) 16:13 Today Stryker reports Q4 adjusted EPS $2.81, consensus $2.55 14:30 Today Notable companies reporting after market close 10/29/20 Stryker does not provide Q4, FY20 sales or earnings guidance 10/29/20 Stryker reports Q3 adjusted EPS $2.14, consensus $1.41 SYK Stryker $230.62 / -7.38 (-3.10%) 10/29/20 Fly Intel: After-Hours Movers 16:30 Today Stryker - SYK
Hot Stocks	Whirlpool CEO says 'we continue to see signs of economic recovery' » 16:14 01/27/21 01/27 16:14 01/27/21 16:14 WHR Whirlpool $214.51 / +8.11 (+3.93%) "Despite a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options WHR Whirlpool $214.51 / +8.11 (+3.93%) 16:09 Today Whirlpool sees FY21 free cash flow of $1B or more 01/11/21 La-Z-Boy appoints Robert Sundy as chief commercial officer 11/16/20 Einhorn's Greenlight buys Twitter, exits Whirlpool in Q3 10/28/20 Whirlpool Chief Legal Officer Kirsten Hewitt to retire, Ava Harter to succeed WHR Whirlpool $214.51 / +8.11 (+3.93%) 12/03/20 JPMorgan Whirlpool added to Analyst Focus List at JPMorgan 11/17/20 Raymond James Major appliance production surged in October, says Raymond James 10/23/20 JPMorgan Whirlpool price target raised to $237 from $192 at JPMorgan 10/23/20 Deutsche Bank Whirlpool price target raised to $199 from $153 at Deutsche Bank WHR Whirlpool $214.51 / +8.11 (+3.93%) 16:06 Today Whirlpool sees FY21 adjusted EPS $19.00-$20.00, consensus $19.10 16:05 Today Whirlpool reports Q4 adjusted EPS $6.64, consensus $6.07 14:30 Today Notable companies reporting after market close 10/21/20 Whirlpool reinstates FY20 adj. EPS view $17.50-$18.00, consensus $13.02 WHR Whirlpool $214.51 / +8.11 (+3.93%) 08/03/20 Trump to visit Clyde's Whirlpool plant this week, Fremont News Messenger reports WHR Whirlpool $214.51 / +8.11 (+3.93%) 10/21/20 Fly Intel: After-Hours Movers 01/28/21 Whirlpool - WHR WHR Whirlpool $214.51 / +8.11 (+3.93%) 10/21/20 Whirlpool options imply 8.7% move in share price post-earnings

Hot Stocks	Tesla sees 2021 as 'even more important' than 2020 » 16:14 01/27/21 01/27 16:14 01/27/21 16:14 TSLA Tesla $862.19 / -21.3 (-2.41%) Tesla said in its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TSLA Tesla $862.19 / -21.3 (-2.41%) 01/26/21 Elon Musk says Tesla 'has better AI hardware and software than Waymo' 01/21/21 Greenlight discloses new positions in Resideo and NCR, discusses FuboTV stake 01/20/21 Chanos says short Tesla stock position transferred into put position 01/19/21 EU passenger car registrations down 3.3% in December TSLA Tesla $862.19 / -21.3 (-2.41%) 08:58 Today Roth Capital Positive results 'clearly' priced into Tesla stock, says Roth Capital 08:42 Today Credit Suisse Positive deliveries guide could be catalyst for Tesla stock, says Credit Suisse 01/26/21 Credit Suisse Credit Suisse could see software, battery as key underpinnings of Apple car 01/25/21 Morgan Stanley Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value TSLA Tesla $862.19 / -21.3 (-2.41%) 16:11 Today Tesla reports Q4 non-GAAP EPS 80c, consensus $1.01 14:30 Today Notable companies reporting after market close 10/21/20 Tesla reports Q3 non-GAAP EPS 76c, consensus 56c 10/21/20 Notable companies reporting after market close 14 Feb TSLA Tesla $862.19 / -21.3 (-2.41%) 01/25/21 Tesla accuses engineer of stealing trade secrets, Business Insider reports 01/22/21 Waymo CEO: Tesla Autopilot will fall short of full autonomy, Bloomberg reports 01/21/21 Tesla's Q4 California registrations inccrease 63%, Reuters reports 01/20/21 Tesla lowers Model 3 prices in Europe, Electrek reports TSLA Tesla $862.19 / -21.3 (-2.41%) 15:10 Today Nokia soars but company 'not aware' of apparent reason for trading activity 12:13 Today Fly Intel: What to watch in Tesla earnings report 01/25/21 Walmart downgrade, Alibaba initiation among today's top calls on Wall Street 01/23/21 Charged: Oppenheimer ups Tesla target to Street-high $1,036 18:30 Today Tesla - TSLA TSLA Tesla $862.19 / -21.3 (-2.41%) 15:04 Today Tesla options imply 13.3% move in share price post-earnings 01/20/21 Notable open interest changes for January 20th 01/13/21 Notable open interest changes for January 13th 01/12/21 Notable open interest changes for January 12th
Hot Stocks	John B. Sanfilippo & Son declares special cash dividend of $2.50 per share » 16:14 01/27/21 01/27 16:14 01/27/21 16:14 JBSS John B. Sanfilippo & Son $78.02 / -3.21 (-3.95%) The Special Dividend will… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events JBSS John B. Sanfilippo & Son $78.02 / -3.21 (-3.95%) 08/19/20 John B. Sanfilippo & Son CEO seeing 'significant improvement in food service' JBSS John B. Sanfilippo & Son $78.02 / -3.21 (-3.95%) 09/04/20 Sidoti John B. Sanfilippo & Son upgraded to Buy from Neutral at Sidoti 04/07/20 Sidoti John B. Sanfilippo & Son downgraded to Neutral from Buy at Sidoti 03/02/20 Sidoti Sidoti upgrades John B. Sanfilippo to Buy, sees little impact from coronavirus 03/02/20 Sidoti John B. Sanfilippo & Son upgraded to Buy from Neutral at Sidoti JBSS John B. Sanfilippo & Son $78.02 / -3.21 (-3.95%) 08/19/20 John B. Sanfilippo & Son reports Q2 EPS 89c, one estimate 91c 01/28/21 John B. Sanfilippo & Son - JBSS
Earnings	RLI Corp. reports Q4 operating EPS 75c, consensus 65c » 16:14 01/27/21 01/27 16:14 01/27/21 16:14 RLI RLI Corp. $98.40 / -3.76 (-3.68%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events RLI RLI Corp. $98.40 / -3.76 (-3.68%) 11/17/20 RLI Corp. names Craig Kliethermes to succeed Jonathan Michael as CEO RLI RLI Corp. $98.40 / -3.76 (-3.68%) 01/06/21 Compass Point RLI Corp. price target raised to $98 from $93 at Compass Point 11/16/20 B. Riley Securities RLI Corp. price target raised to $120 from $110 at B. Riley Securities 09/18/20 Compass Point Compass Point starts RLI Corp. at Neutral with $90 price target 09/17/20 Compass Point RLI Corp. initiated with a Neutral at Compass Point RLI RLI Corp. $98.40 / -3.76 (-3.68%) 10/21/20 RLI reports Q3 ops EPS 42c, consensus 17c RLI RLI Corp. $98.40 / -3.76 (-3.68%) 10/21/20 Fly Intel: After-Hours Movers 02/24/21 22nd Annual Virtual Financial Services Forum 01/28/21 RLI Corp. - RLI
Hot Stocks	Levi Strauss says trends appear to be improving, COVID impact still uncertain » 16:13 01/27/21 01/27 16:13 01/27/21 16:13 LEVI Levi Strauss $22.15 / +0.8 (+3.75%) The company says:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options LEVI Levi Strauss $22.15 / +0.8 (+3.75%) 01/26/21 Target, Levi Strauss expand partnership with limited-edition collection 10/07/20 Levi Strauss CEO: Denim is still bigger than athleisure 10/07/20 Levi Strauss rises 12.6% 10/06/20 Levi Strauss surged 11.4% after upbeat Q3 results LEVI Levi Strauss $22.15 / +0.8 (+3.75%) 06:12 Today Citi Levi Strauss price target raised to $25 from $19 at Citi 01/07/21 JPMorgan Levi Strauss price target raised to $21 from $18 at JPMorgan 12/30/20 Guggenheim Levi Strauss price target raised to $24 from $20 at Guggenheim 12/10/20 Fly Intel: Top five analyst upgrades LEVI Levi Strauss $22.15 / +0.8 (+3.75%) 16:12 Today Levi Strauss reports Q4 EPS 20c, consensus 15c 10/06/20 Levi Strauss reports Q3 adjusted EPS 8c, consensus (22c) LEVI Levi Strauss $22.15 / +0.8 (+3.75%) 12/10/20 Fly Intel: Pre-market Movers 10/07/20 Fly Intel: Wall Street's top stories for Wednesday 10/07/20 Fly Intel: Wall Street's top stories at midday 10/07/20 Fly Intel: Pre-market Movers 17:00 Today Levi Strauss - LEVI LEVI Levi Strauss $22.15 / +0.8 (+3.75%) 10/06/20 Levi Strauss options imply 11.1% move in share price post-earnings
Earnings	Stryker reports Q4 adjusted EPS $2.81, consensus $2.55 » 16:13 01/27/21 01/27 16:13 01/27/21 16:13 SYK Stryker $230.65 / -7.35 (-3.09%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SYK Stryker $230.65 / -7.35 (-3.09%) 01/05/21 Stryker acquires OrthoSensor, terms not disclosed 12/17/20 FTC approves final conditions on Stryker acquisition of Wright Medical 11/11/20 Stryker completes acquisition of Wright Medical 11/11/20 Stryker announces intention to complete Wright Medical acquisition SYK Stryker $230.65 / -7.35 (-3.09%) 01/06/21 Truist Stryker price target raised to $245 from $210 at Truist 01/06/21 Credit Suisse Stryker price target raised to $278 from $253 at Credit Suisse 01/04/21 Guggenheim Stryker resumed with a Neutral at Guggenheim 12/31/20 BTIG Stryker price target raised to $252 from $234 at BTIG SYK Stryker $230.65 / -7.35 (-3.09%) 14:30 Today Notable companies reporting after market close 10/29/20 Stryker does not provide Q4, FY20 sales or earnings guidance 10/29/20 Stryker reports Q3 adjusted EPS $2.14, consensus $1.41 07/30/20 Stryker reports Q2 adj. EPS 64c, consensus 55c SYK Stryker $230.65 / -7.35 (-3.09%) 10/29/20 Fly Intel: After-Hours Movers 16:30 Today Stryker - SYK